Source: Kitsawet Saethao / Getty The first patient to undergo a new and innovative treatment for sickle cell disease is a 12-year-old Black child from Washington D.C. A new commercially approved gene therapy designed to treat and possibly cure sickle therapy had its first patient last Wednesday (May 1). Kendric Cromer, a Black 12-year-old who is from a suburb of Washington, D.C., began his first treatment administered by the Bluebird Bio company at Children’s National Hospital in the D.C. metro... Read this story
